Mounjaro (tirzepatide) is a prescription medication licensed in the UK for the treatment of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with weight-related comorbidities
doi: 10.1016/S2213-8587(22)00340-0 Retrieved from De Block, C., Bailey, C., & Wysham, C
GLP-1 signaling reaches reward circuitry, and early research has examined GLP-1 drugs for various addictive behaviors
If patient not diagnosed, consider additional administration of carnitine 100 mg/kg IV, hydroxycobalamin 1 mg intramuscular/intravenous, and biotin 10 mg IV/peroral, 17 strong recommendation, moderate quality evidence (1B)
The copper-dopamine-norepinephrine pathway explains much of this excess free copper drives excess norepinephrine, producing the stimulated, reactive state that characterizes the clinical picture
Retrieved September 30, 2022